US Edition‘Biotech Barbie’ Says the Time Has Come to Consider CRISPR Babies. Do Scientists Agree?
Manhattan Genomics involves IVF doctors and data scientists to advance ethical gene editing of human embryos, aiming to lift moratoriums on heritable genetic engineering.
5 Articles
5 Articles
‘Biotech Barbie’ says the time has come to consider CRISPR babies. Do scientists agree?
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach. A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Seven years ago, science was shaken by the scandal of Chinese researcher He Jiankui, who announced the birth of the first genetically edited babies. Now, the U.S. company Manhattan Genomics has taken up that idea, with the ambition to “end human genetic diseases by correcting mutations from the embryo,” according to WIRED. His proposal, although it may have an interesting and promising part, is generating controversy and creating a controversial…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
